At close: December 13 at 11:48:25 AM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
211,095.00
159,641.00
106,274.00
56,295.00
26,590.00
Cost of Revenue
47,058.00
39,851.00
25,682.00
16,719.00
5,041.00
Gross Profit
164,037.00
119,790.00
80,592.00
39,576.00
21,549.00
Operating Expense
112,244.00
98,450.00
87,230.00
78,079.00
70,701.00
Operating Income
51,793.00
21,340.00
-6,638.00
-38,503.00
-49,152.00
Net Non Operating Interest Income Expense
3,483.00
2,796.00
1,302.00
369.00
395.00
Pretax Income
55,373.00
25,750.00
1,713.00
-31,692.00
-41,171.00
Tax Provision
26.00
25.00
24.00
22.00
-13.00
Net Income Common Stockholders
55,347.00
25,725.00
1,689.00
-31,714.00
-41,158.00
Diluted NI Available to Com Stockholders
55,347.00
25,725.00
1,689.00
-31,714.00
-41,158.00
Basic EPS
2.82
1.31
0.10
-2.28
-1.81
Diluted EPS
2.80
1.30
0.10
-2.28
-1.81
Basic Average Shares
19,706.76
19,734.33
17,783.54
13,903.89
22,694.60
Diluted Average Shares
19,814.37
19,777.07
17,796.24
13,903.89
22,739.64
Total Operating Income as Reported
--
--
--
-38,503.00
-49,152.00
Total Expenses
159,302.00
138,301.00
112,912.00
94,798.00
75,742.00
Net Income from Continuing & Discontinued Operation
55,347.00
25,725.00
1,689.00
-31,714.00
-41,158.00
Normalized Income
55,347.00
25,725.00
1,689.00
-31,714.00
-41,158.00
Interest Income
3,667.00
3,014.00
1,455.00
578.00
620.00
Interest Expense
184.00
218.00
153.00
209.00
225.00
Net Interest Income
3,483.00
2,796.00
1,302.00
369.00
395.00
EBIT
55,557.00
25,968.00
1,866.00
-31,483.00
-40,946.00
EBITDA
67,227.00
36,611.00
11,375.00
-20,229.00
-28,520.00
Reconciled Cost of Revenue
47,058.00
39,851.00
25,682.00
16,719.00
5,041.00
Reconciled Depreciation
11,670.00
10,643.00
9,509.00
11,254.00
12,426.00
Net Income from Continuing Operation Net Minority Interest
55,347.00
25,725.00
1,689.00
-31,714.00
-41,158.00
Normalized EBITDA
67,227.00
36,611.00
11,375.00
-20,229.00
-28,520.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 7/24/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6861.TW InnoCare Optoelectronics Corporation
61.50
-3.30%
6598.TW Applied BioCode Corporation
21.00
-0.47%
4138.TWO Dynamic Medical Technologies Inc.
91.20
-0.87%
4735.TWO AViTA Corporation
39.55
-2.83%
3218.TWO Universal Vision Biotechnology Co., Ltd.
207.00
-1.90%
6762.TWO Delta Asia International Corporation
273.00
+0.37%
6747.TWO Brighten Optix Corporation
138.50
+0.36%
4736.TW TaiDoc Technology Corporation
146.00
-0.68%
4129.TWO United Orthopedic Corporation
94.10
-1.36%
6796.TW Medimaging Integrated Solution Inc.
82.70
-0.84%